BioCardia Inc (BCDA)
2.40
+0.01
(+0.42%)
USD |
NASDAQ |
Nov 04, 13:00
BioCardia Profit Margin (Quarterly): -54.87K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -54.87K% |
| March 31, 2024 | -4.12K% |
| December 31, 2023 | -15.94K% |
| September 30, 2023 | -721.0% |
| June 30, 2023 | -7.96K% |
| March 31, 2023 | -5.47K% |
| December 31, 2022 | -2.86K% |
| September 30, 2022 | -1.44K% |
| June 30, 2022 | -256.4% |
| March 31, 2022 | -5.54K% |
| December 31, 2021 | -4.38K% |
| September 30, 2021 | -329.6% |
| June 30, 2021 | -5.05K% |
| March 31, 2021 | -6.45K% |
| December 31, 2020 | -6.50K% |
| September 30, 2020 | -11.32K% |
| June 30, 2020 | -13.23K% |
| March 31, 2020 | -12.09K% |
| December 31, 2019 | -1.63K% |
| September 30, 2019 | -1.95K% |
| June 30, 2019 | -4.36K% |
| March 31, 2019 | -1.70K% |
| December 31, 2018 | -3.54K% |
| September 30, 2018 | -4.22K% |
| June 30, 2018 | -1.35K% |
| Date | Value |
|---|---|
| March 31, 2018 | -1.80K% |
| December 31, 2017 | -3.49K% |
| September 30, 2017 | -2.31K% |
| June 30, 2017 | -2.63K% |
| March 31, 2017 | -2.10K% |
| December 31, 2016 | |
| September 30, 2016 | 93.11% |
| June 30, 2016 | 52.82% |
| March 31, 2016 | 55.03% |
| December 31, 2015 | 66.67% |
| September 30, 2015 | 68.60% |
| June 30, 2015 | 58.40% |
| March 31, 2015 | 55.88% |
| December 31, 2014 | 47.66% |
| September 30, 2014 | 44.79% |
| June 30, 2014 | 62.86% |
| March 31, 2014 | 65.31% |
| December 31, 2013 | 5.56% |
| September 30, 2013 | 42.25% |
| June 30, 2013 | 13.04% |
| March 31, 2013 | -65.79% |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | -758.8% |
| March 31, 2012 | -500.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-54.87K%
Minimum
Jun 2024
-256.4%
Maximum
Jun 2022
-8.43K%
Average
-5.47K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -22.27% |
| Theriva Biologics Inc | -- |
| Zevra Therapeutics Inc | -447.9% |
| PetIQ Inc | 4.66% |
| Instil Bio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -228.9% |
| Operating Margin (Quarterly) | -54.97K% |
| Return on Net Operating Assets | -271.4% |